This page includes the latest FDA filings for Napo Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Napo Pharmaceuticals, Inc. | Gelclair® CONCENTRATED ORAL GEL | 2024-09-23 |
| Napo Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Prescription Medication | 2024-02-09 |
| Napo Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Prescription Medication | 2020-11-26 |
| Napo Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Prescription Medication | 2020-03-06 |
| Napo Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Prescription Medication | 2018-03-23 |
| Napo Pharmaceuticals, Inc. | MYTESI | 2016-08-01 |
| NCAGE Code | 5DTK4 | NAPO PHARMACEUTICALS, INC. |
| CAGE Code | 5DTK4 | NAPO PHARMACEUTICALS, INC. |
| SEC | 0001188290 | NAPO PHARMACEUTICALS INC of DELAWARE |